POU2AF3

Chr 11

POU class 2 homeobox associating factor 3

Also known as: C11orf93, CASC13, COLCA2, LOH11CR1G, OCA-T2

Enables DNA binding activity and transcription coactivator activity. Predicted to be involved in DNA-templated transcription and positive regulation of DNA-templated transcription. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
7
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.65
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.65LOEUF
pLI 0.751
Z-score 1.99
OE 0.00 (0.00–0.65)
Moderately constrained

Typical tolerance to LoF variation

Missense Constraint?
0.55Z-score
OE missense 0.82 (0.67–1.01)
62 obs / 75.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.00 (0.00–0.65)
0≤0.351.4
Missense OE?0.82 (0.67–1.01)
0≤0.61.4
Synonymous OE?0.70
0≤1.21.6
LoF obs/exp: 0 / 4.6Missense obs/exp: 62 / 75.5Syn Z: 1.38

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

POU2AF3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →